Eltek Ltd.
(Registrant)
|
|||
By:
|
/s/ Amnon Shemer | ||
Amnon Shemer | |||
Vice President, Finance and
Chief Financial Officer
|
Press Release
|
· |
Revenues for the full year of 2016 amounted to $37.1 million; compared to revenues of $41.4 million in 2015, a decrease of approximately 10.4%.
|
· |
Gross profit was $2.8 million (7.6% of revenues), compared to gross profit of $6.6 million (15.8% of revenues) in 2015;
|
· |
Operating loss was $2 million compared to an operating profit of $1.5 million in 2015;
|
· |
Net loss was $3.6 million or $0.36 per fully diluted share, compared to net profit of 1.0 million or $0.10 per fully diluted share in 2015. Before the $1.1 million write-off of a deferred tax asset and the $271,000 one-time expenses recorded in connection with our sale of Kubatronik, the net loss for the full year of 2016 (on a non-GAAP basis) was $2.3 million, $0.23 per fully diluted share.
|
· |
EBITDA amounted to $(313,000) ((0.8%) of revenues) compared to $3.3 million (8.1% revenues) in 2015;
|
· |
Net cash provided by operating activities amounted to $165,000 compared to $1.7 million in 2015;
|
· |
Cash and cash equivalents as of December 31, 2016 were $1.2 million, compared to $1.0 million as of December 31, 2015. In addition, the Company had un-utilized lines of credit of $1.3 million as of December 31, 2016.
|
· |
Revenues for the fourth quarter of 2016 were $8.1 million compared with revenues of $10.4 million in the fourth quarter of 2015;
|
· |
Gross loss was $463,000 ((5.7%) of revenues) compared with a gross profit of $1.7 million (16.3% of revenues) in the fourth quarter of 2015;
|
· |
Operating loss was $1.6 million compared to an operating profit of $455,000 in the fourth quarter of 2015;
|
· |
Net loss was $3 million or $0.30 per fully diluted share compared to net profit of $228,000 or $0.02 per fully diluted share in the fourth quarter of 2015. The net loss for Q4-2016 (on a non-GAAP basis) was $1.7 million, $0.16 per fully diluted share before the one-time expenses recorded in the fourth quarter of 2016;.
|
· |
EBITDA amounted to $(1.4) million ((17.2%) of revenues) compared to EBITDA of $940,000 (9% of revenues) in the fourth quarter of 2015;
|
· |
Net cash used in operating activities amounted to $1.3 million, compared to $1.4 million of cash provided by operating activities in the fourth quarter of 2015.
|
United States: |
1-888-407-2553
|
Israel: |
03-9180685
|
International: |
+972-3-9180685
|
Three months ended
|
Year ended
|
|||||||||||||||
December 31,
|
December 31,
|
|||||||||||||||
2016
|
2015
|
2016
|
2015
|
|||||||||||||
Revenues
|
8,108
|
10,407
|
37,065
|
41,350
|
||||||||||||
Costs of revenues
|
(8,571
|
)
|
(8,716
|
)
|
(34,248
|
)
|
(34,802
|
)
|
||||||||
Gross profit
|
(463
|
)
|
1,692
|
2,817
|
6,548
|
|||||||||||
Selling, general and administrative expenses
|
(1,130
|
)
|
(1,204
|
)
|
(4,699
|
)
|
(4,961
|
)
|
||||||||
R&D expenses, net
|
(20
|
)
|
(33
|
)
|
(117
|
)
|
(90
|
)
|
||||||||
Operating profit (loss)
|
(1,612
|
)
|
455
|
(1,999
|
)
|
1,497
|
||||||||||
Financial expenses, net
|
(98
|
)
|
(115
|
)
|
(309
|
)
|
(259
|
)
|
||||||||
Profit (loss) before other income, net
|
(1,710
|
)
|
339
|
(2,308
|
)
|
1,238
|
||||||||||
Other income, net
|
(259
|
)
|
1
|
(259
|
)
|
6
|
||||||||||
Profit (loss) before income tax expenses
|
(1,969
|
)
|
340
|
(2,567
|
)
|
1,244
|
||||||||||
Tax expenses
|
(1,080
|
)
|
(142
|
)
|
(1,158
|
)
|
(218
|
)
|
||||||||
Net Profit (loss)
|
(3,050
|
)
|
198
|
(3,725
|
)
|
1,026
|
||||||||||
Net loss attributable to non controlling interest
|
(43
|
)
|
(30
|
)
|
(101
|
)
|
(17
|
)
|
||||||||
Net Profit (loss) attributable to Eltek Ltd.
|
(3,007
|
)
|
228
|
(3,624
|
)
|
1,043
|
||||||||||
Earnings per share
|
||||||||||||||||
Basic and diluted net gain (loss) per ordinary share
|
(0.30
|
)
|
0.02
|
(0.36
|
)
|
0.10
|
||||||||||
Weighted average number of ordinary shares
|
||||||||||||||||
used to compute basic and diluted net gain (loss) per
|
||||||||||||||||
ordinary share (in thousands)
|
10,143
|
10,143
|
10,143
|
10,143
|
December 31,
|
December 31,
|
|||||||
2016
|
2015
|
|||||||
Assets
|
||||||||
Current assets
|
||||||||
Cash and cash equivalents
|
1,234
|
1,038
|
||||||
Receivables: Trade, net of provision for doubtful accounts
|
5,704
|
8,015
|
||||||
Other
|
205
|
273
|
||||||
Inventories
|
3,926
|
4,450
|
||||||
Prepaid expenses
|
251
|
187
|
||||||
Total current assets
|
11,320
|
13,963
|
||||||
Deferred taxes
|
0
|
1,064
|
||||||
Assets held for employees' severance benefits
|
50
|
49
|
||||||
Fixed assets, less accumulated depreciation
|
8,453
|
10,067
|
||||||
Intangible asset
|
322
|
276
|
||||||
Total assets
|
20,145
|
25,419
|
||||||
Liabilities and Shareholder's equity
|
||||||||
Current liabilities
|
||||||||
Short-term credit and current maturities of long-term debts
|
2,868
|
1,275
|
||||||
Accounts payable: Trade
|
4,727
|
6,112
|
||||||
Other
|
3,818
|
4,594
|
||||||
Total current liabilities
|
11,413
|
11,981
|
||||||
Long-term liabilities
|
||||||||
Long term debt, excluding current maturities
|
1,954
|
2,905
|
||||||
Employee severance benefits
|
144
|
289
|
||||||
Total long-term liabilities
|
2,098
|
3,194
|
||||||
Equity
|
||||||||
Ordinary shares, NIS 0.6 par value authorized 50,000,000 shares, issued and outstanding 10,142,762
|
1,985
|
1,985
|
||||||
Additional paid-in capital
|
17,270
|
17,270
|
||||||
Cumulative foreign currency translation adjustments
|
1,815
|
1,892
|
||||||
Capital reserve
|
695
|
695
|
||||||
Accumulated deficit
|
(15,131
|
)
|
(11,507
|
)
|
||||
Shareholders' equity
|
6,634
|
10,335
|
||||||
Non controlling interest
|
0
|
(91
|
)
|
|||||
Total equity
|
6,634
|
10,244
|
||||||
Total liabilities and shareholders' equity
|
20,145
|
25,419
|
Non-GAAP EBITDA Reconciliations
|
Three months ended
|
Year ended
|
||||||||||||||
December 31,
|
December 31,
|
|||||||||||||||
2016
|
2015
|
2016
|
2015
|
|||||||||||||
GAAP net Income (loss)
|
(3,007
|
)
|
228
|
(3,624
|
)
|
1,043
|
||||||||||
Add back items:
|
||||||||||||||||
Financial expenses (income), net
|
98
|
116
|
309
|
259
|
||||||||||||
Income tax expense
|
1,080
|
142
|
1,158
|
218
|
||||||||||||
Depreciation and amortization
|
431
|
455
|
1,844
|
1,816
|
||||||||||||
Adjusted EBITDA
|
(1,396
|
)
|
940
|
(313
|
)
|
3,335
|
Three months ended
|
Year ended
|
|||||||||||||||
December 31,
|
December 31,
|
|||||||||||||||
2016
|
2015
|
2016
|
2015
|
|||||||||||||
GAAP net Income (loss)
|
(3,007
|
)
|
228
|
(3,624
|
)
|
1,043
|
||||||||||
Add back items:
|
||||||||||||||||
Decrease (increase) in deferred tax assets
|
1,063
|
1,063
|
||||||||||||||
Sale of Kubatronik
|
271
|
271
|
||||||||||||||
Net Profit (loss) before change in deferred tax assets,
management downsizing and an impairment of goodwill (non-GAAP)
|
(1,673
|
)
|
228
|
(2,290
|
)
|
1,043
|
||||||||||
Basic and diluted net gain (loss) per ordinary share
|
(0.16
|
)
|
0.02
|
(0.23
|
)
|
0.10
|
Three months ended
|
Year ended
|
|||||||||||||||
December 31,
|
December 31,
|
|||||||||||||||
2016
|
2015
|
2016
|
2015
|
|||||||||||||
Cash flows from operating activities:
|
||||||||||||||||
Net Income (loss)
|
(3,050
|
)
|
228
|
(3,725
|
)
|
1,026
|
||||||||||
Adjustments to reconcile net loss to net
|
||||||||||||||||
cash flows provided by operating activities:
|
||||||||||||||||
Depreciation and amortization
|
443
|
408
|
1,856
|
1,731
|
||||||||||||
Capital lose on disposal of fixed assets, net
|
(12
|
)
|
9
|
(12
|
)
|
85
|
||||||||||
Revaluation of long term loans
|
-
|
133
|
1
|
10
|
||||||||||||
Decrease (increase) in Deferred Tax
|
1,062
|
(7
|
)
|
1,083
|
133
|
|||||||||||
1,492
|
657
|
2,929
|
1,959
|
|||||||||||||
Decrease (increase) in trade receivables
|
641
|
142
|
2,143
|
171
|
||||||||||||
Decrease (increase) in other receivables and prepaid expenses
|
17
|
277
|
(97
|
)
|
249
|
|||||||||||
Decrease (increase) in inventories
|
504
|
158
|
289
|
213
|
||||||||||||
Increase (decrease) in trade payables
|
(378
|
)
|
(311
|
)
|
(561
|
)
|
(1,396
|
)
|
||||||||
Increase (decrease) in other liabilities and accrued expenses
|
(409
|
)
|
157
|
(664
|
)
|
(543
|
)
|
|||||||||
Increase (decrease) in employee severance benefits, net
|
(148
|
)
|
61
|
(150
|
)
|
41
|
||||||||||
226
|
484
|
961
|
(1,265
|
)
|
||||||||||||
Net cash provided by operating activities
|
(1,331
|
)
|
1,370
|
165
|
1,720
|
|||||||||||
Proceeds from sale of investments in previously consolidated subsidiaries:
|
||||||||||||||||
The subsidiaries' assets and liabilities at date of sale:
|
||||||||||||||||
Trade accounts receivable net
|
290
|
-
|
290
|
|||||||||||||
Inventories
|
298
|
-
|
298
|
|||||||||||||
Prepaid and other current assets
|
107
|
-
|
107
|
|||||||||||||
Assets held for employees' severance benefits
|
-
|
-
|
-
|
|||||||||||||
Property, plant and equipment
|
537
|
-
|
537
|
|||||||||||||
-
|
-
|
-
|
||||||||||||||
deferred Tax - Long Term
|
-
|
-
|
-
|
|||||||||||||
Goodwill/intangible asset
|
(0
|
)
|
-
|
(0
|
)
|
|||||||||||
Short-term credit
|
-
|
-
|
-
|
|||||||||||||
Trade
|
(604
|
)
|
-
|
(604
|
)
|
|||||||||||
Other
|
(185
|
)
|
-
|
(185
|
)
|
|||||||||||
Long-term debt, including current maturities
|
(112
|
)
|
-
|
(112
|
)
|
|||||||||||
Employee severance benefits
|
(276
|
)
|
-
|
(276
|
)
|
|||||||||||
Investment in company accounted for at equity
|
191
|
-
|
191
|
|||||||||||||
245
|
-
|
245
|
||||||||||||||
Cash flows from investing activities:
|
||||||||||||||||
Owners investment
|
||||||||||||||||
Purchase of fixed assets
|
(146
|
)
|
(194
|
)
|
(708
|
)
|
(797
|
)
|
||||||||
Purchase of Intangible asset
|
-
|
(69
|
)
|
(43
|
)
|
(69
|
)
|
|||||||||
Net cash used in investing activities
|
(146
|
)
|
(263
|
)
|
(750
|
)
|
(866
|
)
|
||||||||
Cash flows from financing activities:
|
||||||||||||||||
Increase (decrease) in short- term credit
|
1,657
|
(1,083
|
)
|
1,589
|
(2,063
|
)
|
||||||||||
Repayment of long-term loans from bank
|
(175
|
)
|
(76
|
)
|
(680
|
)
|
(207
|
)
|
||||||||
Proceeds from long-term loans
|
199
|
-
|
199
|
1,707
|
||||||||||||
Repayment of credit from fixed asset payables
|
(83
|
)
|
(136
|
)
|
(635
|
)
|
(505
|
)
|
||||||||
Net cash provided by (used in) financing activities
|
1,598
|
(1,294
|
)
|
473
|
(1,068
|
)
|
||||||||||
Effect of translation adjustments
|
25
|
7
|
37
|
123
|
||||||||||||
Net increase (decrease) in cash and cash equivalents
|
392
|
(181
|
)
|
196
|
(91
|
)
|
||||||||||
Cash and cash equivalents at beginning of the period
|
842
|
1,179
|
1,038
|
1,129
|
||||||||||||
-
|
||||||||||||||||
Cash and cash equivalents at period end
|
1,234
|
998
|
1,234
|
1,038
|
||||||||||||
1,234
|
998
|
1,208
|
1,038
|